News from NYU Langone Health
Physical Therapist Explains Why Knicks Can Rest Easy ѵ Josh Hart’s Injury. (New York Post)
The (2/20) Josh Hart of the Knicks is sidelined with Patellofemoral Pain Syndrome, a condition often referred to as “runner’s knee,” and Charles Homoky, PT, DPT, physical therapist, Sports Performance Center, said it is unlikely to derail an athlete’s season, as overuse is the most common cause, with treatment options varying from physical therapy to stretching, and rarely requiring surgery.
Is Giancarlo Stanton In Danger Of Missing Start Of Yankees Season? (New York Post)
The (2/20) Craig A. Pille, MD, clinical assistant professor, Department of Orthopedic Surgery, joins Brandon London to break down Giancarlo Stanton’s injury. Dr. Pille describes what may be going on with Yankees’ Giancarlo Stanton after Aaron Boone described it as, ‘tennis elbow,’ and what this means for Stanton in the upcoming weeks.”
I’m A Cardiologist – Why You Shouldn’t Trust Your Blood Pressure Reading At Your Doctor’s Office. (New York Post)
The (2/20) Stephen K. Williams, MD, assistant professor, Departments of Medicine, the Leon H. Charney Division of Cardiology, and Population Health, said that relying solely on blood pressure readings taken in a doctor’s office can lead to misdiagnosis, advocating instead for home measurements for accuracy, as they better reflect a patient’s typical condition; he also criticized the use of BMI as a health measure, suggesting DEXA Scan with VAT analysis as a superior method to assess visceral adipose tissue, which is crucial for understanding risks related to heart disease, stroke, and other conditions.
Drug Overdose Deaths Fall In 2023 For 1st Time Since Pandemic Began: CDC. (ABC News)
(2/20) The Centers for Disease Control and Prevention’s National Center for Health Statistics reported a 4% decrease in U.S. drug overdose deaths, dropping from 32.6 to 31.3 per 100,000 people between 2022 and 2023, with Magdalena Cerda, DrPH, professor, Department of Population Health, attributing the decline to a potential decrease in fentanyl supply and stabilization of the drug market; however, overdose death rates increased in six states including California, with the nationwide death rate from synthetic opioids like fentanyl decreasing slightly, while rates for psychostimulants and cocaine rose.
Cocaine Use Is Rising... Here Are The States Where People Use The Most. (Daily Mail (UK))
The (2/20) New CDC data indicates fatalities linked to cocaine rose nearly five percent from 2022 to 2023 and have increased roughly 60 percent since 2015, with Joseph J. Palamar, MPH, PhD, associate professor, Department of Population Health, noting this trend is driven by the co-use of cocaine and fentanyl, which he describes as “the fourth wave of the opioid crisis.”
Addressing LGBTQ+ Microaggressions In Cancer Care. (Everyday Health)
(2/20) Gwendolyn P. Quinn, PhD, the Livia S. Wan, M.D. Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, and professor, Department of Population Health, Perlmutter Cancer Center, co-authored an editorial in Frontiers in Oncology calling for more inclusive LGBTQ+ cancer care and training programs for healthcare providers to better understand the needs of LGBTQ+ patients.
FDA Clears Updated Ezra Flash AI Software For MRI Scans. (Diagnostic Imaging)
(2/20) The FDA has granted 510(k) clearance for Ezra’s AI software, Ezra Flash AI, which enhances MRI scan quality for the brain, abdomen, and pelvis by reducing noise while maintaining diagnostic integrity, and Daniel K. Sodickson, MD, PhD, professor, Departments of Radiology, and Neuroscience and Physiology, said, “The FDA clearance of Ezra Flash represents a significant advancement in making AI-powered cancer screening more accessible,” adding that it facilitates faster, more accurate early cancer detection, providing clearer insights for informed healthcare decisions.
Key Trials From ASH 2024 Impact Treatment For Plasma Cell Disorders Going Forward. (Targeted Oncology)
(2/20) Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, Division of Medical Oncology and Hematology, Perlmutter Cancer Center, NYU Langone Hospital—Long Island, discussed at the 2024 ASH Annual Meeting the advancements in multiple myeloma treatment, including the efficacy of daratumumab in combination therapies, the promising outcomes of CAR T-cell therapy, and how these developments could influence treatment strategies in 2025, emphasizing the importance of monoclonal antibodies in improving patient outcomes and the potential for CAR T-cell therapy to become a standard in early relapse settings.
Unintended Weight Loss Before Kidney Transplant Evaluation Tied To Lower Listing Odds. (Healio)
(2/20) A recent study found that stable weight, unintentional weight loss, and weight gain are associated with lower odds of waitlisting for frail candidates with obesity, with Nidhi Ghildayal, PhD, MPH, senior research scientist, and colleagues noting that, “Clinical guidelines recommend weight loss for [end-stage kidney disease] ESKD patients with obesity to enhance KT candidacy.”
Fluoride In Water Supply Not A Risk, Says Ethicist. (Medscape)
Paywalled* (2/20)* The issue of fluoride in the water supply has been reignited by Robert F. Kennedy Jr., despite longstanding evidence supporting its effectiveness in preventing dental cavities, as noted by Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, who expressed concern over the implications of shifting fluoride application from water to dental visits, particularly for low-income children.
Advanced Adenomas Signal Higher Risk For CRC, Mortality. (Medscape)
Paywalled* (2/21)* A study led by Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, published in JAMA Network Open, found that individuals with advanced and nonadvanced adenomas detected during colonoscopy are at a significantly higher risk for developing colorectal cancer compared to those without adenomas, with advanced adenomas also linked to increased colorectal cancer-related and all-cause mortality over 20 years, while nonadvanced adenomas did not significantly affect mortality outcomes.
NYU Langone Health Takes Over Rothman’s 21K SF At 645 Madison Avenue. (Commercial Observer (NY))
The (2/20) NYU Langone Health is moving into Rothman Orthopaedics of Greater New York’s 21,461 square-foot office at 645 Madison Avenue as part of its acquisition of the medical practice; the acquisition also includes locations in Tarrytown and Harrison, N.Y., and incorporates 13 orthopedic specialists into NYU Langone Health’s ambulatory network, focusing on sports medicine, spine, joint, and rehabilitation medicine.
Clinical Insights, Strategies For Delivering Equitable Psoriatic Arthritis Care. (American Journal of Managed Care)
(2/20) Rebecca Haberman, MD, assistant professor, Department of Medicine, Division of Rheumatology, discusses findings indicating that Hispanic and non-White patients with psoriatic arthritis experience higher tender joint counts and more radiographic axial disease, emphasizing the need for clinicians to recognize diverse presentations and provide equitable care.
Why ‘Date Caramel’ Is The Healthy Coffee Creamer Swap You Need To Try. (Verywell Health)
(2/20) Date caramel, a blend of soaked dates and other ingredients, is gaining popularity as a coffee creamer alternative, offering health benefits from its fiber and essential nutrients, but it is also high in sugar; Rabia A. De Latour, MD, assistant professor, Department of Medicine, Division of Gastroenterology and Hepatology, said, “The sugar [in dates] that everyone talks about is all-natural sugar, which is why I would pick a date over a synthetic, processed creamer from the store any day.”
Overreact Much? How To Lower The Temp, Prevent Arguments, And Save Friends. (Yahoo! Lifestyle)
(2/19) Emotional reactivity, characterized by impulsive reactions to stress or discomfort, is common in interpersonal relationships, often leading to misunderstandings and hurt feelings, with psychologist Rachel L. Goldman, PhD, clinical assistant professor, Department of Psychiatry, saying “Emotional reactivity is when you’re feeling stressed, or emotional, and you react out of that emotion in an impulsive, or in an emotional manner.”
Blood Test May Provide New Option For Colorectal Cancer Screening. (Pulmonology Advisor)
(2/20) A blood-based test (Freenome) is being evaluated as a new option for colorectal cancer screening in the average-risk U.S. population, according to research presented at the American Society of Clinical Oncology’s annual Gastrointestinal Cancers Symposium; Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health, and colleagues assessed the test’s performance in a validation cohort of 27,010 participants, finding it had an 81.1 percent sensitivity for colorectal cancer and a 90.4 percent specificity for those without advanced colorectal neoplasia, with Dr. Shaukat stating, “Additional colorectal cancer screening tests that are convenient, safe, and easy to complete are needed.”
